Literature DB >> 4143953

Parkinson's disease: from brain homogenate to treatment.

O Hornykiewicz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4143953

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


× No keyword cloud information.
  26 in total

Review 1.  The biochemistry of the basal ganglia and Parkinson's disease.

Authors:  G Curzon
Journal:  Postgrad Med J       Date:  1977-12       Impact factor: 2.401

2.  Further aspects of nomifensine pharmacology.

Authors:  B Costall; R J Naylor
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

Review 3.  Hyperpolarization-activated, cyclic nucleotide-gated (HCN) channels in the regulation of midbrain dopamine systems.

Authors:  Hong-yuan Chu; Xuechu Zhen
Journal:  Acta Pharmacol Sin       Date:  2010-08-02       Impact factor: 6.150

4.  Low lumbar CSF levels of homovanillic acid and 5-hydroxyindoleacetic acid in multiple system atrophy with autonomic failure.

Authors:  R J Polinsky; R T Brown; R S Burns; J Harvey-White; I J Kopin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

5.  Transneuronal transport of peroxidase-conjugated wheat germ agglutinin (WGA-HRP) from the olfactory epithelium to the brain of the adult rat.

Authors:  H Baker; R F Spencer
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Dopamine-sensitive adenylate cyclase activity in the striatum in Parkinson's disease.

Authors:  M Shibuya
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

7.  Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts.

Authors:  Suman Patel; Kavita Singh; Seema Singh; Mahendra Pratap Singh
Journal:  Mol Biotechnol       Date:  2008-04-02       Impact factor: 2.695

8.  Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Authors:  Feifei Wang; Takao Yasuhara; Tetsuro Shingo; Masahiro Kameda; Naoki Tajiri; Wen Ji Yuan; Akihiko Kondo; Tomohito Kadota; Tanefumi Baba; Judith Thomas Tayra; Yoichiro Kikuchi; Yasuyuki Miyoshi; Isao Date
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

9.  Neurotoxic effects of methamphetamine.

Authors:  Bessy Thrash; Senthilkumar S Karuppagounder; Subramaniam Uthayathas; Vishnu Suppiramaniam; Muralikrishnan Dhanasekaran
Journal:  Neurochem Res       Date:  2009-08-21       Impact factor: 3.996

10.  Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.

Authors:  G R Breese; A A Baumeister; T J McCown; S G Emerick; G D Frye; K Crotty; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.